Abiopharma

Clinical trial NCT07111520 updates: 1. completion date: 2030-01-01 → 2030-06-01 2. primary completion date: 2029-01-01 → 2028-11-01 3. enrollment: 420 → 880 participants

Clinical trial NCT07173803 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-30 → 2026-07-29

Clinical trial NCT07564141: start date: 2026-07-01 → 2026-08-01.

Clinical trial NCT07205367 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-10-31 → 2025-11-07 3. allocation: NA → NON_RANDOMIZED

Clinical trial NCT06254911: status: SUSPENDED → RECRUITING.

Clinical trial NCT03157635 updates: 1. completion date: 2026-09-30 → 2026-08-13 2. primary completion date: 2026-09-30 → 2026-08-13

Clinical trial NCT07673367: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT02502786 updates: 1. completion date: 2026-07-01 → 2027-07-01 2. primary completion date: 2026-07-01 → 2027-07-01

Clinical trial NCT06809140: enrollment: 47 → 75 participants.

Clinical trial NCT06266663 updates: 1. completion date: 2026-06-30 → 2026-09-30 2. primary completion date: 2026-06-30 → 2026-09-30

Clinical trial NCT07704892 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-20 → 2026-07-22 3. completion date: 2033-12-06 → 2033-12-08 4. primary completion date: 2030-10-14 → 2030-10-16

Clinical trial NCT07256756: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT06473961 updates: 1. completion date: 2027-07-01 → 2028-07-01 2. primary completion date: 2026-01-01 → 2027-01-01

Clinical trial NCT06706076: enrollment: 266 → 675 participants.

Clinical trial NCT07504601: start date: 2026-08-07 → 2026-08-10.